down arrow

Shukra Pharma.

42
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE551C01044
  • NSEID:
  • BSEID: 524632
INR
18.62
-0.38 (-2.0%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 7.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 26.75% vs 187.19% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 261.78% vs 85.86% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 1.50% vs -2.02% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 320.68% vs 486.99% in Mar 2023

Compare Profit and Loss Results of Shukra Pharma.
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
74.00
9,264.00
-9,190.00
-99.20%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
74.00
9,264.00
-9,190.00
-99.20%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-25.00
25.00
100.00%
Raw Materials Consumed
43.00
2,933.00
-2,890.00
-98.53%
Power & Fuel Cost
0.00
70.00
-70.00
-100.00%
Employee Cost
5.00
1,982.00
-1,977.00
-99.75%
Operating Expenses
0.00
143.00
-143.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
806.00
-804.00
-99.75%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
136.00
-136.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
55.00
6,939.00
-6,884.00
-99.21%
Operating Profit (PBDIT) excl Other Income
19.00
2,325.00
-2,306.00
-99.18%
Other Income
2.00
266.00
-264.00
-99.25%
Operating Profit (PBDIT)
22.00
2,592.00
-2,570.00
-99.15%
Interest
0.00
15.00
-15.00
-100.00%
Profit before Depriciation and Tax
21.00
2,577.00
-2,556.00
-99.19%
Depreciation
2.00
317.00
-315.00
-99.37%
Profit Before Taxation & Exceptional Items
19.00
2,259.00
-2,240.00
-99.16%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
19.00
2,259.00
-2,240.00
-99.16%
Provision for Tax
1.00
436.00
-435.00
-99.77%
Profit After Tax
18.00
1,823.00
-1,805.00
-99.01%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
19.00
7,868.00
-7,849.00
-99.76%
Profit Available for appropriations
37.00
9,691.00
-9,654.00
-99.62%
Appropriations
37.00
9,691.00
-9,654.00
-99.62%
Equity Dividend (%)
10%
0%
10.00
Earnings Per Share
16.93
45.52
-28.59
-62.81%
Profit And Loss - Net Sales
Net Sales 74.57 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 26.75% vs 187.19% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.40 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 261.78% vs 85.86% in Mar 2023

Profit And Loss - Interest
Interest 0.28 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 1.50% vs -2.02% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 18.54 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 320.68% vs 486.99% in Mar 2023